In-depth interviews and an online survey found support for gene therapy as a treatment for inherited blood disorders, but ...

Silvan Tuerkcan, an analyst from JMP Securities, maintained the Buy rating on Taysha Gene Therapies (TSHA – Research Report). The ...

RCCS San Raffaele Scientific Institute in Milan researchers have discovered that hematopoietic stem cells (HSCs) adapt their lineage commitment during gene therapy based on the underlying genetic ...

NGGT has initiated Phase I/II clinical trials in the U.S. and China to evaluate the safety and efficacy of NGGT002 for the <a ta ...

Needham analyst Gil Blum maintained a Buy rating on Taysha Gene Therapies (TSHA – Research Report) today and set a price target of $6.00.

Weight-loss surgery in adolescents with severe obesity can lead to long-term health benefits, such as more frequent remission ...

The advantages of amnionic fluid stem cells Because they can develop into several cell types amniotic fluid stem cells AFSCs have great potential in the field of regenerative medicine Their multipoten ...

Vizient surveys the impact of AI in healthcare and advancements in pediatric gene therapy in the latest Pediatric Tech Watch.

The results in Alzheimer's come a few months after Lexeo also reported encouraging data with its gene therapy for ...

Funding to support clinical proof-of-concept for the lead program, VIPER-101 PHILADELPHIA, Nov. 12, 2024 (GLOBE NEWSWIRE) -- ...